MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e67581
Publisher
Public Library of Science (PLoS)
Online
2013-06-22
DOI
10.1371/journal.pone.0067581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-372 Is Associated with Poor Prognosis in Colorectal Cancer
- (2017) Shinya Yamashita et al. ONCOLOGY
- PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription
- (2012) Kaijie Wu et al. CELLULAR SIGNALLING
- Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
- (2012) Y. Kim et al. GENES & DEVELOPMENT
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
- (2012) Julian R. Molina et al. MAYO CLINIC PROCEEDINGS
- Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKB Phosphorylation of RhoC GTPase
- (2012) H. L. Lehman et al. MOLECULAR CANCER RESEARCH
- miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis
- (2012) Joachim Silber et al. PLoS One
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and -103, Target the Differentiation Inhibitor ID2
- (2012) Daniela Annibali et al. PLoS One
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA hypermethylation of microRNA-34b/c has prognostic value for stage Ⅰ non-small cell lung cancer
- (2011) Zhen Wang et al. CANCER BIOLOGY & THERAPY
- Targeting Trail Towards the Clinic
- (2011) Devalingam Mahalingam et al. CURRENT DRUG TARGETS
- MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma
- (2011) Nannan Wu et al. FEBS Journal
- Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
- (2011) Chor Sang Chim et al. Journal of Translational Medicine
- Genome-wide Characterization ofmiR-34aInduced Changes in Protein and mRNA Expression by a Combined Pulsed SILAC and Microarray Analysis
- (2011) Markus Kaller et al. MOLECULAR & CELLULAR PROTEOMICS
- Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion
- (2011) H Feng et al. ONCOGENE
- Advanced Malignant Lung Disease: What the Specialist Can Offer
- (2011) D. Gompelmann et al. RESPIRATION
- Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
- (2010) Dmitri Lodygin et al. CELL CYCLE
- miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- (2009) Michela Garofalo et al. CANCER CELL
- A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets
- (2009) Gerard J Nuovo et al. Nature Protocols
- Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells
- (2008) Tom Donnem et al. Journal of Thoracic Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started